Uncross-matched blood is unnecessary

Hospital Medicine

Volumn 66, Issue 2, 2005, Pages 96-98

  Thomas, Michael J G ^a  

^a Blood Care Foundation   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGENIC BONE MARROW TRANSPLANTATION; BLOOD COMPATIBILITY; BLOOD TRANSFUSION; BONE MARROW; CONFERENCE PAPER; HEMATOCRIT; HOSPITAL CARE; HUMAN; LENGTH OF STAY; OXYGEN DISSOCIATION CURVE; PHYLOGENY; RISK ASSESSMENT;

EID: 13944269250     PISSN: 14623935     EISSN: None     Source Type: Journal    
DOI: 10.12968/hmed.2005.66.2.17556     Document Type: Conference Paper

References (11)

1. Bickell WH, Wall MJ Jnr, Pepe PE et al (1994) Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med 331: 1105-9
2. Gould SA, Moore EE, Hoyt DB et al (2002) The life-saving capacity of human polymerized haemoglobin when red cells might be unavailable. J Am Coll Surg 195(4): 445-55
3. Hess J, Thomas MJG (2003) Blood use in war and disaster: lessons from the past century. Transfusion 43(11): 1622-33
4. Jacobs KM (1994) Timing of fluid resuscitation in trauma. N Engl J Med 331: 1153-4
5. Key NS, Aledort LM, Beardsley D et al (1998) Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (NovoSeven) in haemophiliacs with inhibitors. Thromb Haemost 80(6): 912-18
6. Levy JH, Goodnpugh LT, Greilich PE et al (2002) Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: results of a randomized, double-blind trial. J Thorac Cardiovasc Surg 124(1): 35-42
7. Messmer K, Sunder-Plassman L, Klovekorn W, Holper K (1972) Circulatory significance of hemodilution: rheological changes and limitations. Adv Microcirculation 4: 1-77
8. Messmer K (1988) Hemodilution - possibilities and safety aspects. Acta Anaesthesiol Scand 32(Suppl 89): 49-53
9. Silliman CC, Moore EE, Johnson JL et al (2004) Transfusion of the injured patient: proceed with caution. Shock 21(4): 291-9
10. Thomas MJG (1999) Infected and malignant fields are an absolute contraindication to intraoperative cell salvage: fact or fiction? Transfus Med 9(3): 269-78
11. Wright FL, Hong MS, Hua T et al (2004) Intracorporeal use of the hemostatic agent QuickClot in a coagulopathic patient with combined thoracoabdominal penetrating trauma. J Trauma 56(1): 205-8